Hepatocellular carcinoma
- PMID: 38086315
- DOI: 10.1016/j.ejso.2023.107313
Hepatocellular carcinoma
Abstract
An update on the management of Hepatocellular carcinoma (HCC) is provided in the present article for those interested in the UEMS/EBSQ exam in Surgical Oncology. The most recent publications in HCC, including surveillance, guidelines, and indications for liver resection, liver transplantation, and locoregional or systemic therapies, are summarised. The objective is to yield a set of main points regarding HCC that are required in the core curriculum of hepatobiliary oncological surgery.
Keywords: Hepatocellular carcinoma; Liver resection; Liver transplantation; Locoregional therapies; Surveillance; Systemic therapies.
© 2023 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
[Curative therapy of hepatocellular carcinoma (HCC). Resection or transplantation?].Internist (Berl). 2000 Feb;41(2 Pt 2):191-7. doi: 10.1007/s001080050024. Internist (Berl). 2000. PMID: 10756434 Review. German. No abstract available.
-
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5. Radiology. 2015. PMID: 25203131
-
Technical Aspects of Orthotopic Liver Transplantation for Hepatocellular Carcinoma.Surg Clin North Am. 2016 Apr;96(2):269-81. doi: 10.1016/j.suc.2015.11.004. Epub 2016 Feb 16. Surg Clin North Am. 2016. PMID: 27017864 Review.
-
Surgical resection and liver transplantation for hepatocellular carcinoma.Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2. Clin Liver Dis. 2015. PMID: 25921669 Review.
-
Surgical treatment of hepatocellular carcinoma.Biosci Trends. 2021 Jul 6;15(3):138-141. doi: 10.5582/bst.2021.01094. Epub 2021 Mar 19. Biosci Trends. 2021. PMID: 33746184 Review.
Cited by
-
MiR-145-5p inhibits proliferation of hepatocellular carcinoma, acting through PAI-1.Am J Transl Res. 2025 Feb 15;17(2):888-896. doi: 10.62347/NPLT8946. eCollection 2025. Am J Transl Res. 2025. PMID: 40092137 Free PMC article.
-
Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis.Am J Cancer Res. 2025 Feb 15;15(2):517-532. doi: 10.62347/SXMJ5155. eCollection 2025. Am J Cancer Res. 2025. PMID: 40084372 Free PMC article.
-
TTLL4 mediates the PI3K/AKT/MDM2 pathway to promote hepatocellular carcinoma progression and predict patient prognosis.APL Bioeng. 2025 Jun 30;9(2):026128. doi: 10.1063/5.0267938. eCollection 2025 Jun. APL Bioeng. 2025. PMID: 40599993 Free PMC article.
-
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA.Cell Biochem Biophys. 2024 Sep;82(3):1947-1964. doi: 10.1007/s12013-024-01395-6. Epub 2024 Jul 10. Cell Biochem Biophys. 2024. PMID: 38987439 Review.
-
PPIH Expression Correlates with Tumor Aggressiveness and Immune Dysregulation in Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2024 Dec 11;11:2453-2470. doi: 10.2147/JHC.S492420. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39679070 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
